⌕

Alnylam Pharmaceuticals (ALNY) vs United Therapeutics (UTHR)

Your goal
● Balanced style: every factor counts equally.
#1 FIT · LEADS
73
United Therapeutics Corp
$591.17 · $25B · as of last close
Street favoriteBest returnsCheapest
of the stocks compared here

The front-runner. Leads the balanced score. Its widest win over the field is analyst sentiment.

#2 FIT
43
Alnylam Pharmaceuticals Inc
$165.04 · $22B · as of last close

The challenger. Trails the leader on the balanced score. It wins no row outright; growth is its closest.

UTHR leads clearly (73/100 vs ALNY 43) under a balanced style, mostly on analyst sentiment. Switch your goal above and watch the scores move.

THE SCORECARD · FACTOR BY FACTOR · the best value in each row is ticked, and a tie ticks every tied column · weight bar shows how much it counts for your goal

FactorALNYUTHR
Overall fit score
weighted for your balanced goal
43
✓ 73
Valuation
Cheaper for what you get
1×
P/E 71 · EV/EBITDA 36.3
P/E fiscal 2025
16
✓ P/E 22 · EV/EBITDA 16.3
P/E trailing
59
P/E bases differ: fiscal 2025 for ALNY, trailing for UTHR.
Growth
Revenue & earnings momentum
1×
✓ —
75
✓ —
75
Profitability & quality
Margins & return on capital
1×
Net 8% · ROIC 27%
fiscal 2025
71
✓ Net 39% · ROIC 17%
TTM through Sep 30, 2026
77
Total return
Share-price change with dividends reinvested
1×
5Y −2%/yr
42
✓ 5Y +24%/yr
86
Risk (calm = better)
Volatility & drawdown
1×
β 0.7 · DD −69%
59
✓ β 0.4 · DD −33%
87
Balance sheet†
Debt vs cash cushion
1×
Net debt/EBITDA −3.4×
fiscal 2025
44
✓ Net debt/EBITDA −1.5×
TTM through Sep 30, 2026
79
Dividend & income
Cash paid to you
1×
✓ —
40
✓ —
40
Analyst sentiment
Forward EPS growth (consensus)
1×
Est EPS −51%/yr · 16 analysts
0
✓ Est EPS +21%/yr · 10 analysts
81
† Balance sheet is scored on 5 peer percentiles (current ratio, quick ratio, net debt/EBITDA, interest coverage and debt/equity). The cell shows one of them, so a column can lead on the printed number and still lose the row.
Loading chart…
WHERE EACH ONE IS STRONG
GrowthValueQualityReturnSafetyIncome
■ ALNY■ UTHR
CAN YOU STOMACH THE RIDE?
Worst drawdown3-year beta vs S&P 500VolatilityHistory
ALNY−69%0.7552%5Y
UTHR−33%0.4035%5Y
Drawdown and volatility are measured over five years on the same total return as the chart, dividends reinvested.
THE CASE FOR & AGAINST EACH
BULL CASE

▲ Best factor is growth: — (score 75).

BEAR CASE

▼ Weakest on analyst sentiment: Est EPS −51%/yr · 16 analysts (score 0).

▼ Weakest on total return: 5Y −2%/yr (score 42).

BULL CASE

▲ Leads on analyst sentiment: Est EPS +21%/yr · 10 analysts (score 81).

▲ Leads on total return: 5Y +24%/yr (score 86).

BEAR CASE

▼ Even its softest factor holds up: dividend & income at 40.

WHAT COULD CHANGE THE SCORE
Analyst sentimentCurrently 0/100 (Est EPS −51%/yr · 16 analysts). Taking it to 100 would lift the balanced score by 13 points, the biggest single move available.
ValuationCurrently 16/100 (P/E 71 · EV/EBITDA 36.3). Taking it to 100 would lift the balanced score by 11 points, the next biggest.
Dividend & incomeCurrently 40/100 (—). Taking it to 100 would lift the balanced score by 8 points, the biggest single move available.
ValuationCurrently 59/100 (P/E 22 · EV/EBITDA 16.3). Taking it to 100 would lift the balanced score by 5 points, the next biggest.
Scores are Tenet composites, 0–100, reweighted for your selected goal. Seven of the eight factors are sector percentiles; analyst sentiment is an absolute curve on forward EPS growth, capped at 100, so two very high-growth names can share the top score. Moat/durability is not scored (qualitative, not measurable). Comparison is decision-support, not a recommendation · past performance does not predict future returns · Not investment advice · prices are each company's own latest close, the newest here being Nov 13, 2026 · valuation, growth, quality and balance scores from the Nov 13, 2026 scoring run · analyst consensus, return, risk and income scores computed Nov 13, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.